Identification of and Structural Insights into Hit Compounds Targeting N-Myristoyltransferase for Cryptosporidium Drug Development

Structural overlays help to rationalize the SAR for 18 , 19 and 23

Structure-Based Design of Potent and Selective Leishmania N- Myristoyltransferase Inhibitors

PDF) Structure-Based Design of Potent and Selective Leishmania N- Myristoyltransferase Inhibitors

N-myristoyltransferase inhibitors as new leads to treat sleeping sickness. - Abstract - Europe PMC

Targeting RNA structures with small molecules

Structure-guided discovery of potent human NMT inhibitors a, Structures

Identification of and Structural Insights into Hit Compounds Targeting N- Myristoyltransferase for Cryptosporidium Drug Development

Identification of and Structural Insights into Hit Compounds Targeting N- Myristoyltransferase for Cryptosporidium Drug Development

Identification of and Structural Insights into Hit Compounds Targeting N- Myristoyltransferase for Cryptosporidium Drug Development

Frontiers Cryptosporidium parvum Pyruvate Kinase Inhibitors With in vivo Anti-cryptosporidial Efficacy

PDF) Pharmacological Validation of N-Myristoyltransferase as a Drug Target in Leishmania donovani

Discovery of a Novel Class of Orally Active Trypanocidal N- Myristoyltransferase Inhibitors

Genetic modification of the diarrhoeal pathogen Cryptosporidium parvum. - Abstract - Europe PMC